J&J Recalling 60,000 Bottles of Tylenol, Citing Musty Odor

Johnson & Johnson (JNJ) said it is recalling more than 60,000 bottles of Tylenol Extra Strength caplets because of a musty odor that has led the company to withdraw dozens of other products since last year.

The voluntary recall was prompted by “a small number of odor reports,” New Brunswick, New Jersey-based J&J’s McNeil Consumer Healthcare unit said today in a statement. While the risk of serious medical problems is remote, the odor has been linked to a chemical that can cause “temporary and non-serious gastrointestinal symptoms,” the company said.

J&J, the world’s second-largest maker of health-care products, has pulled millions of packages of over-the-counter drugs since last year because of the chemical known as 2,4,6 tribromoanisole, used to treat wooden shipping and storage pallets. The company pulled 40,000 bottles of Risperdal, a schizophrenia drug, on June 17 because of the chemical’s musty odor, which also led the company to recall shipments of the HIV drug Prezista and the seizure medicine Topamax this year.

The 60,912 bottles of Tylenol recalled today make up one lot of the product and were manufactured in February 2009, J&J said in the statement.

To contact the reporter on this story: Molly Peterson in Washington at mpeterson9@bloomberg.net

To contact the editor responsible for this story: Adriel Bettelheim at abettelheim@bloomberg.net

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.